Treatment with GSK3326595 significantly diminished tumor growth in the mice (Fig. 5j, k), accompanied by decreased H4R3me2s and downregulation of CDK4/6 in the drug-treated tumors (Fig. 5l). The gene discussed is CDK4; the disease is neoplasm.